Related Experiment Video

Updated: Aug 7, 2026

Functional Characterization of Endogenously Expressed Human RYR1 Variants
07:59

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Published on: June 9, 2021

Human cardiac ryanodine receptor mutations in ion channel disorders in Japan

Yoshiyasu Aizawa, Wataru Mitsuma, Taruna Ikrar

    International Journal of Cardiology
    |July 18, 2006
    PubMed

    Insights

    Genetic screening identified mutations in the cardiac ryanodine receptor gene (RyR2) in 75% of Japanese families with catecholaminergic polymorphic ventricular tachycardia (CPVT). No RyR2 mutations were found in other studied heart rhythm disorders.

    Area of Science:

    • Cardiology
    • Genetics
    • Molecular Biology

    Background:

    • Catecholaminergic polymorphic ventricular tachycardia (CPVT) involves adrenergic-induced ventricular arrhythmias.
    • Previous studies linked some CPVT cases to cardiac ryanodine receptor gene (RyR2) mutations.
    • The role of RyR2 mutations in other arrhythmogenic disorders remained unclear.

    Discussion:

    • This study investigated RyR2 mutations in 83 Japanese patients across various inherited arrhythmia syndromes, including CPVT, long-QT syndrome, Brugada syndrome, idiopathic ventricular fibrillation, and arrhythmogenic right ventricular cardiomyopathy.
    • RyR2 mutations were identified in 75% of CPVT families (3 distinct mutations in 4 families).
    • No RyR2 mutations were detected in patients with other investigated arrhythmogenic disorders.

    Key Insights:

    • RyR2 mutations are a frequent cause of CPVT in the Japanese population.
    • RyR2 mutations appear specific to CPVT and not associated with other common inherited arrhythmia syndromes.
    • This research clarifies the genetic basis of CPVT in Japan.

    Outlook:

    • Further research may explore the functional consequences of identified RyR2 mutations.
    • Investigating other genetic factors in non-RyR2 related CPVT is warranted.
    • Understanding RyR2 mutation prevalence can aid in diagnosing and managing CPVT patients.

    More Related Videos

    Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia09:36

    Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

    Published on: December 22, 2023

    Crystal Structure of the N-terminal Domain of Ryanodine Receptor from Plutella xylostella11:31

    Crystal Structure of the N-terminal Domain of Ryanodine Receptor from Plutella xylostella

    Published on: November 30, 2018

    Related Concept Videos

    Mechanism of Cardiac Arrhythmias01:28

    Mechanism of Cardiac Arrhythmias

    Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
    Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

    Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

    Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
    Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
    Heart Failure Drugs: Inotropic Agents01:26

    Heart Failure Drugs: Inotropic Agents

    Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
    Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

    Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

    Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...